BCL2L15 cDNA ORF clone, Homo sapiens(human)

  • Gene

  • Clones

  • gRNAs

The following BCL2L15 gene cDNA ORF clone sequences were retrieved from the NCBI Reference Sequence Database (RefSeq). These sequences represent the protein coding region of the BCL2L15 cDNA ORF which is encoded by the open reading frame (ORF) sequence. ORF sequences can be delivered in our standard vector, pcDNA3.1+/C-(K)DYK or the vector of your choice as an expression/transfection-ready ORF clone. Not the clone you want? Click here to find your clone.

***CloneID Accession No. Definition **Vector *Turnaround time Price (USD) Select
OHu16197 NM_001010922.3
Latest version!
Homo sapiens BCL2 like 15 (BCL2L15), mRNA. pcDNA3.1-C-(k)DYK or customized vector
in pcDNA3.1-C-(k)DYK
$49.50-$69.30
$99.00
View Old Accession Versions >>
OHu16197 NM_001010922.2 Homo sapiens BCL2 like 15 (BCL2L15), mRNA. pcDNA3.1-C-(k)DYK or customized vector
in pcDNA3.1-C-(k)DYK
$49.50-$69.30
$99.00
Hide Old Accession Versions >>

ORF Online Only Promotion

Next-day Shipping ORF Clones ( in default vector with tag)
1 Clone 30% OFF
2-4 Clone 40% OFF
5 or more Clone 50% OFF
All Other ORF Clones
30% OFF

*Business Day

** You may select a custom vector to replace pcDNA3.1+/C-(K)DYK after clone is added to cart.

** GenScript guarantees 100% sequence accuracy of all synthetic DNA constructs we deliver, but we do not guarantee protein expression in your experimental system. Protein expression is influenced by many factors that may vary between experiments or laboratories. In addition, please pay attention to the signal peptide, propeptide and transit peptide in target ORF, which may affect the choice of vector (N/C terminal tag vector).

***One clone ID might be correlated to multiple accession numbers, which share the same CDS sequence.

  • Reference Sequences (Refseq)
    CloneID OHu16197
    Clone ID Related Accession (Same CDS sequence) NM_001010922.3 , NM_001010922.2
    Accession Version NM_001010922.3 Latest version! Documents for ORF clone product in default vector
    Sequence Information ORF Nucleotide Sequence (Length: 492bp)
    Protein sequence
    SNP
    Vector pcDNA3.1-C-(k)DYK or customized vector User Manual
    Clone information Clone Map MSDS
    Tag on pcDNA3.1+/C-(K)DYK C terminal DYKDDDDK tags
    ORF Insert Method CloneEZ™ Seamless cloning technology
    Insert Structure linear
    Update Date 2019-04-30
    Organism Homo sapiens(human)
    Product bcl-2-like protein 15
    Comment Comment: VALIDATED REFSEQ: This record has undergone validation or preliminary review. The reference sequence was derived from AL137856.24, AI821052.1, AY265861.1 and BX116361.1. On Nov 22, 2018 this sequence version replaced NM_001010922.2. ##Evidence-Data-START## Transcript exon combination :: AK289439.1, BM829833.1 [ECO:0000332] RNAseq introns :: single sample supports all introns SAMEA2142586, SAMEA2154405 [ECO:0000348] ##Evidence-Data-END## ##RefSeq-Attributes-START## MANE Ensembl match :: ENST00000393316.8/ ENSP00000376992.3 RefSeq Select criteria :: based on single protein-coding transcript ##RefSeq-Attributes-END## COMPLETENESS: full length.

    1
    61
    121
    181
    241
    301
    361
    421
    481
    ATGAAGAGCT CCCAAACTTT TGAGGAACAA ACGGAATGCA TTGTGAACAC TCTACTCATG 
    GACTTCTTGA GCCCAACATT GCAGGTTGCC AGCCGGAACC TATGCTGTGT AGATGAAGTA
    GATTCAGGAG AGCCTTGTTC TTTTGATGTG GCTATCATTG CTGGTCGCCT TCGGATGTTG
    GGTGACCAGT TCAACGGAGA ATTGGAAGCT TCTGCCAAAA ACGTCATTGC AGAAACCATT
    AAGGGACAGA CAGGAGCTAT ACTCCAGGAC ACTGTGGAAT CTCTCAGCAA GACCTGGTGT
    GCTCAGGATT CCAGCTTAGC TTATGAGAGA GCTTTTCTGG CAGTGTCAGT GAAACTTCTT
    GAGTACATGG CTCACATTGC TCCTGAAGTA GTGGGACAGG TGGCTATCCC CATGACGGGT
    ATGATCAATG GGAACCAAGC CATCCGGGAG TTCATCCAGG GCCAGGGAGG TTGGGAAAAT
    CTGGAGAGCT GA

    The stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.

    RefSeq NP_001010922.1
    CDS207..698
    Translation

    Target ORF information:

    RefSeq Version NM_001010922.3
    Organism Homo sapiens(human)
    Definition Homo sapiens BCL2 like 15 (BCL2L15), mRNA.

    Target ORF information:

    Epitope DYKDDDDK
    Bacterial selection AMPR
    Mammalian selection NeoR
    Vector pcDNA3.1+/C-(K)DYK
    NM_001010922.3

    ORF Insert Sequence:

    1
    61
    121
    181
    241
    301
    361
    421
    481
    ATGAAGAGCT CCCAAACTTT TGAGGAACAA ACGGAATGCA TTGTGAACAC TCTACTCATG 
    GACTTCTTGA GCCCAACATT GCAGGTTGCC AGCCGGAACC TATGCTGTGT AGATGAAGTA
    GATTCAGGAG AGCCTTGTTC TTTTGATGTG GCTATCATTG CTGGTCGCCT TCGGATGTTG
    GGTGACCAGT TCAACGGAGA ATTGGAAGCT TCTGCCAAAA ACGTCATTGC AGAAACCATT
    AAGGGACAGA CAGGAGCTAT ACTCCAGGAC ACTGTGGAAT CTCTCAGCAA GACCTGGTGT
    GCTCAGGATT CCAGCTTAGC TTATGAGAGA GCTTTTCTGG CAGTGTCAGT GAAACTTCTT
    GAGTACATGG CTCACATTGC TCCTGAAGTA GTGGGACAGG TGGCTATCCC CATGACGGGT
    ATGATCAATG GGAACCAAGC CATCCGGGAG TTCATCCAGG GCCAGGGAGG TTGGGAAAAT
    CTGGAGAGCT GA

    The stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.

    CloneID OHu16197
    Clone ID Related Accession (Same CDS sequence) NM_001010922.3 , NM_001010922.2
    Accession Version NM_001010922.2 Documents for ORF clone product in default vector
    Sequence Information ORF Nucleotide Sequence (Length: 492bp)
    Protein sequence
    SNP
    Vector pcDNA3.1-C-(k)DYK or customized vector User Manual
    Clone information Clone Map MSDS
    Tag on pcDNA3.1+/C-(K)DYK C terminal DYKDDDDK tags
    ORF Insert Method CloneEZ™ Seamless cloning technology
    Insert Structure linear
    Update Date 2017-10-01
    Organism Homo sapiens(human)
    Product bcl-2-like protein 15
    Comment Comment: VALIDATED REFSEQ: This record has undergone validation or preliminary review. The reference sequence was derived from AI821052.1, AY265861.1, AL137856.24 and BX116361.1. On Jan 12, 2007 this sequence version replaced NM_001010922.1. ##Evidence-Data-START## Transcript exon combination :: AK289439.1, BM829833.1 [ECO:0000332] RNAseq introns :: single sample supports all introns SAMEA2142586, SAMEA2154405 [ECO:0000348] ##Evidence-Data-END## COMPLETENESS: complete on the 3' end.

    1
    61
    121
    181
    241
    301
    361
    421
    481
    ATGAAGAGCT CCCAAACTTT TGAGGAACAA ACGGAATGCA TTGTGAACAC TCTACTCATG 
    GACTTCTTGA GCCCAACATT GCAGGTTGCC AGCCGGAACC TATGCTGTGT AGATGAAGTA
    GATTCAGGAG AGCCTTGTTC TTTTGATGTG GCTATCATTG CTGGTCGCCT TCGGATGTTG
    GGTGACCAGT TCAACGGAGA ATTGGAAGCT TCTGCCAAAA ACGTCATTGC AGAAACCATT
    AAGGGACAGA CAGGAGCTAT ACTCCAGGAC ACTGTGGAAT CTCTCAGCAA GACCTGGTGT
    GCTCAGGATT CCAGCTTAGC TTATGAGAGA GCTTTTCTGG CAGTGTCAGT GAAACTTCTT
    GAGTACATGG CTCACATTGC TCCTGAAGTA GTGGGACAGG TGGCTATCCC CATGACGGGT
    ATGATCAATG GGAACCAAGC CATCCGGGAG TTCATCCAGG GCCAGGGAGG TTGGGAAAAT
    CTGGAGAGCT GA

    The stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.

    RefSeq NP_001010922.1
    CDS173..664
    Translation

    Target ORF information:

    RefSeq Version NM_001010922.2
    Organism Homo sapiens(human)
    Definition Homo sapiens BCL2 like 15 (BCL2L15), mRNA.

    Target ORF information:

    Epitope DYKDDDDK
    Bacterial selection AMPR
    Mammalian selection NeoR
    Vector pcDNA3.1+/C-(K)DYK
    NM_001010922.2

    ORF Insert Sequence:

    1
    61
    121
    181
    241
    301
    361
    421
    481
    ATGAAGAGCT CCCAAACTTT TGAGGAACAA ACGGAATGCA TTGTGAACAC TCTACTCATG 
    GACTTCTTGA GCCCAACATT GCAGGTTGCC AGCCGGAACC TATGCTGTGT AGATGAAGTA
    GATTCAGGAG AGCCTTGTTC TTTTGATGTG GCTATCATTG CTGGTCGCCT TCGGATGTTG
    GGTGACCAGT TCAACGGAGA ATTGGAAGCT TCTGCCAAAA ACGTCATTGC AGAAACCATT
    AAGGGACAGA CAGGAGCTAT ACTCCAGGAC ACTGTGGAAT CTCTCAGCAA GACCTGGTGT
    GCTCAGGATT CCAGCTTAGC TTATGAGAGA GCTTTTCTGG CAGTGTCAGT GAAACTTCTT
    GAGTACATGG CTCACATTGC TCCTGAAGTA GTGGGACAGG TGGCTATCCC CATGACGGGT
    ATGATCAATG GGAACCAAGC CATCCGGGAG TTCATCCAGG GCCAGGGAGG TTGGGAAAAT
    CTGGAGAGCT GA

    The stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.

  • PubMed

    Large-scale genotyping identifies 41 new loci associated with breast cancer risk.
    Nature genetics45(4)353-61, 361e1-2(2013 Apr)
    Michailidou K,Hall P,Gonzalez-Neira A,Ghoussaini M,Dennis J,Milne RL,Schmidt MK,Chang-Claude J,Bojesen SE,Bolla MK,Wang Q,Dicks E,Lee A,Turnbull C,Rahman N,,Fletcher O,Peto J,Gibson L,Dos Santos Silva I,Nevanlinna H,Muranen TA,Aittom?ki K,Blomqvist C,Czene K,Irwanto A,Liu J,Waisfisz Q,Meijers-Heijboer H,Adank M,,van der Luijt RB,Hein R,Dahmen N,Beckman L,Meindl A,Schmutzler RK,M?ller-Myhsok B,Lichtner P,Hopper JL,Southey MC,Makalic E,Schmidt DF,Uitterlinden AG,Hofman A,Hunter DJ,Chanock SJ,Vincent D,Bacot F,Tessier DC,Canisius S,Wessels LF,Haiman CA,Shah M,Luben R,Brown J,Luccarini C,Schoof N,Humphreys K,Li J,Nordestgaard BG,Nielsen SF,Flyger H,Couch FJ,Wang X,Vachon C,Stevens KN,Lambrechts D,Moisse M,Paridaens R,Christiaens MR,Rudolph A,Nickels S,Flesch-Janys D,Johnson N,Aitken Z,Aaltonen K,Heikkinen T,Broeks A,Veer LJ,van der Schoot CE,Gu?nel P,Truong T,Laurent-Puig P,Menegaux F,Marme F,Schneeweiss A,Sohn C,Burwinkel B,Zamora MP,Perez JI,Pita G,Alonso MR,Cox A,Brock IW,Cross SS,Reed MW,Sawyer EJ,Tomlinson I,Kerin MJ,Miller N,Henderson BE,Schumacher F,Le Marchand L,Andrulis IL,Knight JA,Glendon G,Mulligan AM,,,Lindblom A,Margolin S,Hooning MJ,Hollestelle A,van den Ouweland AM,Jager A,Bui QM,Stone J,Dite GS,Apicella C,Tsimiklis H,Giles GG,Severi G,Baglietto L,Fasching PA,Haeberle L,Ekici AB,Beckmann MW,Brenner H,M?ller H,Arndt V,Stegmaier C,Swerdlow A,Ashworth A,Orr N,Jones M,Figueroa J,Lissowska J,Brinton L,Goldberg MS,Labr?che F,Dumont M,Winqvist R,Pylk?s K,Jukkola-Vuorinen A,Grip M,Brauch H,Hamann U,Br?ning T,,Radice P,Peterlongo P,Manoukian S,Bonanni B,Devilee P,Tollenaar RA,Seynaeve C,van Asperen CJ,Jakubowska A,Lubinski J,Jaworska K,Durda K,Mannermaa A,Kataja V,Kosma VM,Hartikainen JM,Bogdanova NV,Antonenkova NN,D?rk T,Kristensen VN,Anton-Culver H,Slager S,Toland AE,Edge S,Fostira F,Kang D,Yoo KY,Noh DY,Matsuo K,Ito H,Iwata H,Sueta A,Wu AH,Tseng CC,Van Den Berg D,Stram DO,Shu XO,Lu W,Gao YT,Cai H,Teo SH,Yip CH,Phuah SY,Cornes BK,Hartman M,Miao H,Lim WY,Sng JH,Muir K,Lophatananon A,Stewart-Brown S,Siriwanarangsan P,Shen CY,Hsiung CN,Wu PE,Ding SL,Sangrajrang S,Gaborieau V,Brennan P,McKay J,Blot WJ,Signorello LB,Cai Q,Zheng W,Deming-Halverson S,Shrubsole M,Long J,Simard J,Garcia-Closas M,Pharoah PD,Chenevix-Trench G,Dunning AM,Benitez J,Easton DF


    Bfk, a novel member of the bcl2 gene family, is highly expressed in principal cells of the mouse epididymis and demonstrates a predominant nuclear localization.
    Endocrinology148(7)3196-204(2007 Jul)
    Pujianto DA,Damdimopoulos AE,Sipil? P,Jalkanen J,Huhtaniemi I,Poutanen M


    Differential expression of apoptosis-related proteins in various cellular components of ameloblastomas.
    International journal of oral and maxillofacial surgery35(8)750-5(2006 Aug)
    Luo HY,Yu SF,Li TJ


    Expression of pro-apoptotic Bfk isoforms reduces during malignant transformation in the human gastrointestinal tract.
    FEBS letters579(17)3646-50(2005 Jul)
    Dempsey CE,Dive C,Fletcher DJ,Barnes FA,Lobo A,Bingle CD,Whyte MK,Renshaw SA


    Bfk: a novel weakly proapoptotic member of the Bcl-2 protein family with a BH3 and a BH2 region.
    Cell death and differentiation10(2)185-92(2003 Feb)
    Coultas L,Pellegrini M,Visvader JE,Lindeman GJ,Chen L,Adams JM,Huang DC,Strasser A